{"nct_id":"NCT01275209","title":"Study of HCD122 (Lucatumumab) and Bendamustine Combination Therapy in CD40+ Rituximab-refractory Follicular Lymphoma","status":"COMPLETED","status_verified_date":"2012-12","start_date":"2011-02","start_date_type":null,"primary_completion_date":"2012-05","primary_completion_date_type":"ACTUAL","completion_date":"2012-05","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["NVS"]}